logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10172942 B1

PDFFull Text
Date of Patent:
Jan. 08, 2019

Filed:

Dec. 10, 2015

Formulations of a pi3k/mtor-inhibitor for intravenous administration

Applicant:

Pfizer Inc., New York, NY (US);

Inventors:

Kevin Richard Back, Sandwich, GB;

Michael Cram, Sandwich, GB;

Aidan James Harper, Sandwich, GB;

W. James Huang, New York, NY (US);

Jonathan Richard Lillis, Sandwich, GB;

Timothy Michael Lukas, Sandwich, GB;

Sumit Luthra, New York, NY (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorney:

David Rubin

Primary Examiner:

Shirley V Gembeh

Int. Cl.
CPC ...
A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 47/02 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 9/19 (2006.01); A61K 31/5377 (2006.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
A61K 47/12 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 9/19 (2013.01); A61K 31/5377 (2013.01); A61K 47/02 (2013.01); A61K 47/26 (2013.01); C07D 401/12 (2013.01); C07B 2200/13 (2013.01);
Abstract

The present invention relates to a pharmaceutical aqueous formulation comprising -(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. Such a formulation is particularly suitable for intravenous or parenteral administration to a patient.

Find Patent Forward Citations

Quick Actions:

Back, Kevin. (2019). Formulations of a pi3k/mtor-inhibitor for intravenous administration (U.S. Patent No. 10172942). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10172942

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…